• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPP2R2D 抑制 IL-2 的产生和 Treg 功能。

PPP2R2D suppresses IL-2 production and Treg function.

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Boston, Masschusetts, USA.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

JCI Insight. 2020 Oct 2;5(19):138215. doi: 10.1172/jci.insight.138215.

DOI:10.1172/jci.insight.138215
PMID:32897879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7566706/
Abstract

Protein phosphatase 2A is a ubiquitously expressed serine/threonine phosphatase that comprises a scaffold, a catalytic, and multiple regulatory subunits and has been shown to be important in the expression of autoimmunity. We considered that a distinct subunit may account for the decreased production of IL-2 in people and mice with systemic autoimmunity. We show that the regulatory subunit PPP2R2D is increased in T cells from people with systemic lupus erythematosus and regulates IL-2 production. Mice lacking PPP2R2D only in T cells produce more IL-2 because the IL-2 gene and genes coding for IL-2-enhancing transcription factors remain open, while the levels of the enhancer phosphorylated CREB are high. Mice with T cell-specific PPP2R2D deficiency display less systemic autoimmunity when exposed to a TLR7 stimulator. While genes related to Treg function do not change in the absence of PPP2R2D, Tregs exhibit high suppressive function in vitro and in vivo. Because the ubiquitous expression of protein phosphatase 2A cannot permit systemic therapeutic manipulation, the identification of regulatory subunits able to control specific T cell functions opens the way for the development of novel, function-specific drugs.

摘要

蛋白磷酸酶 2A 是一种普遍表达的丝氨酸/苏氨酸磷酸酶,由支架、催化和多个调节亚基组成,已被证明在自身免疫的表达中很重要。我们认为,一个独特的亚基可能是导致系统性自身免疫患者和小鼠 IL-2 产量减少的原因。我们发现,系统性红斑狼疮患者的 T 细胞中,调节亚基 PPP2R2D 增加,并调节 IL-2 的产生。仅在 T 细胞中缺乏 PPP2R2D 的小鼠会产生更多的 IL-2,因为 IL-2 基因和编码增强 IL-2 转录因子的基因保持开放,而增强子磷酸化 CREB 的水平较高。当暴露于 TLR7 激动剂时,T 细胞特异性 PPP2R2D 缺乏的小鼠表现出较少的系统性自身免疫。虽然缺乏 PPP2R2D 时与 Treg 功能相关的基因没有改变,但 Treg 在体外和体内均表现出高抑制功能。由于蛋白磷酸酶 2A 的广泛表达不能允许系统性治疗干预,因此能够控制特定 T 细胞功能的调节亚基的鉴定为开发新型、功能特异性药物开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/31b2c2a8e7e0/jciinsight-5-138215-g048.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/0ac4665977b5/jciinsight-5-138215-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/79956a38d8f9/jciinsight-5-138215-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/3dc925ab06df/jciinsight-5-138215-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/5051d5d102d4/jciinsight-5-138215-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/557eada8fa8b/jciinsight-5-138215-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/31b2c2a8e7e0/jciinsight-5-138215-g048.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/0ac4665977b5/jciinsight-5-138215-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/79956a38d8f9/jciinsight-5-138215-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/3dc925ab06df/jciinsight-5-138215-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/5051d5d102d4/jciinsight-5-138215-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/557eada8fa8b/jciinsight-5-138215-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd6/7566706/31b2c2a8e7e0/jciinsight-5-138215-g048.jpg

相似文献

1
PPP2R2D suppresses IL-2 production and Treg function.PPP2R2D 抑制 IL-2 的产生和 Treg 功能。
JCI Insight. 2020 Oct 2;5(19):138215. doi: 10.1172/jci.insight.138215.
2
PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.PPP2R2D 抑制效应 T 细胞耗竭和调节性 T 细胞扩增并抑制黑色素瘤肿瘤生长。
J Immunol. 2022 Aug 1;209(3):621-628. doi: 10.4049/jimmunol.2200041. Epub 2022 Jul 13.
3
The PP2A regulatory subunit PPP2R2A controls NAD biosynthesis to regulate T cell subset differentiation in systemic autoimmunity.PP2A 调节亚基 PPP2R2A 控制 NAD 生物合成以调节系统性自身免疫中的 T 细胞亚群分化。
Cell Rep. 2024 Jul 23;43(7):114379. doi: 10.1016/j.celrep.2024.114379. Epub 2024 Jun 17.
4
The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.蛋白磷酸酶 2A 的调节亚基 PPP2R2A 通过激活 GEF-H1/RhoA/ROCK 信号通路增强 Th1 和 Th17 分化。
J Immunol. 2021 Apr 15;206(8):1719-1728. doi: 10.4049/jimmunol.2001266. Epub 2021 Mar 24.
5
PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.PPP2R2D,蛋白磷酸酶 2A 的调节亚基,通过雷帕霉素靶蛋白的激活促进胃癌的生长和转移。
Int J Oncol. 2018 Jun;52(6):2011-2020. doi: 10.3892/ijo.2018.4329. Epub 2018 Mar 20.
6
Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.诱导型蛋白磷酸酶 2A Bβ,白细胞介素-2 剥夺诱导 T 细胞凋亡的调节因子,在系统性红斑狼疮中缺乏。
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12443-8. doi: 10.1073/pnas.1103915108. Epub 2011 Jul 11.
7
Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp Risk Allele Drive the Expansion of FOXP3 Regulatory T Cells and PD-1 Expression.系统性红斑狼疮中的慢性免疫激活以及自身免疫性 PTPN22 Trp 风险等位基因驱动 FOXP3 调节性 T 细胞和 PD-1 表达的扩增。
Front Immunol. 2019 Nov 8;10:2606. doi: 10.3389/fimmu.2019.02606. eCollection 2019.
8
PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.PP2A 通过在调节性 T 细胞发育过程中维持 IL-2Rβ 链的表达来增强 IL-2 信号。
JCI Insight. 2019 Mar 26;5(9):126294. doi: 10.1172/jci.insight.126294.
9
[Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].[系统性红斑狼疮中白细胞介素-2信号通路调节分子]
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Dec 18;48(6):1100-1104.
10
The serine/threonine protein phosphatase 2A controls autoimmunity.丝氨酸/苏氨酸蛋白磷酸酶 2A 控制自身免疫。
Clin Immunol. 2018 Jan;186:38-42. doi: 10.1016/j.clim.2017.07.012. Epub 2017 Jul 21.

引用本文的文献

1
Protein phosphatases in systemic autoimmunity.系统性自身免疫中的蛋白磷酸酶。
Immunometabolism (Cobham). 2025 Feb 10;7(1):e00056. doi: 10.1097/IN9.0000000000000056. eCollection 2025 Jan.
2
The PP2A regulatory subunit PPP2R2A controls NAD biosynthesis to regulate T cell subset differentiation in systemic autoimmunity.PP2A 调节亚基 PPP2R2A 控制 NAD 生物合成以调节系统性自身免疫中的 T 细胞亚群分化。
Cell Rep. 2024 Jul 23;43(7):114379. doi: 10.1016/j.celrep.2024.114379. Epub 2024 Jun 17.
3
MicroRNA-5010-5p ameliorates high-glucose induced inflammation in renal tubular epithelial cells by modulating the expression of PPP2R2D.

本文引用的文献

1
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.白介素-2 治疗可减轻狼疮肾炎小鼠的肾脏炎症和肾浸润 CD4+T 细胞的活性。
Cells. 2019 Oct 11;8(10):1234. doi: 10.3390/cells8101234.
2
PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.PP2A 通过在调节性 T 细胞发育过程中维持 IL-2Rβ 链的表达来增强 IL-2 信号。
JCI Insight. 2019 Mar 26;5(9):126294. doi: 10.1172/jci.insight.126294.
3
Regulatory T cells in the treatment of disease.调节性 T 细胞在疾病治疗中的应用。
miR-5010-5p 通过调控 PPP2R2D 的表达改善高糖诱导的肾小管上皮细胞炎症反应。
BMJ Open Diabetes Res Care. 2024 Mar 4;12(2):e003784. doi: 10.1136/bmjdrc-2023-003784.
4
Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease.系统性红斑狼疮中动脉粥样硬化风险预测与监测的潜在生物标志物更新以预防心血管疾病
Biomedicines. 2023 Oct 17;11(10):2814. doi: 10.3390/biomedicines11102814.
5
RAS and PP2A activities converge on epigenetic gene regulation.RAS 和 PP2A 活性集中于表观遗传基因调控。
Life Sci Alliance. 2023 Mar 1;6(5). doi: 10.26508/lsa.202301928. Print 2023 May.
6
The star target in SLE: IL-17.SLE 的明星靶点:IL-17。
Inflamm Res. 2023 Feb;72(2):313-328. doi: 10.1007/s00011-022-01674-z. Epub 2022 Dec 20.
7
Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics.调节性 T 细胞稳态:必需的信号及其对生物制剂临床开发的影响。
Clin Immunol. 2023 Jan;246:109201. doi: 10.1016/j.clim.2022.109201. Epub 2022 Dec 5.
8
PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.PPP2R2D 抑制效应 T 细胞耗竭和调节性 T 细胞扩增并抑制黑色素瘤肿瘤生长。
J Immunol. 2022 Aug 1;209(3):621-628. doi: 10.4049/jimmunol.2200041. Epub 2022 Jul 13.
9
Genetic Variations Controlling Regulatory T Cell Development and Activity in Mouse Models of Lupus-Like Autoimmunity.控制狼疮样自身免疫小鼠模型中调节性 T 细胞发育和活性的遗传变异。
Front Immunol. 2022 May 26;13:887489. doi: 10.3389/fimmu.2022.887489. eCollection 2022.
10
The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.蛋白磷酸酶 2A 的调节亚基 PPP2R2A 通过激活 GEF-H1/RhoA/ROCK 信号通路增强 Th1 和 Th17 分化。
J Immunol. 2021 Apr 15;206(8):1719-1728. doi: 10.4049/jimmunol.2001266. Epub 2021 Mar 24.
Nat Rev Drug Discov. 2018 Nov;17(11):823-844. doi: 10.1038/nrd.2018.148. Epub 2018 Oct 12.
4
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues.一种改进的ATAC-seq方案可减少背景干扰,并能够对冷冻组织进行检测。
Nat Methods. 2017 Oct;14(10):959-962. doi: 10.1038/nmeth.4396. Epub 2017 Aug 28.
5
An essential role for the IL-2 receptor in T cell function.白细胞介素-2受体在T细胞功能中起重要作用。
Nat Immunol. 2016 Nov;17(11):1322-1333. doi: 10.1038/ni.3540. Epub 2016 Sep 5.
6
The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.癌症信号通路中失灵的“关闭”开关:蛋白磷酸酶2A作为肿瘤发生、耐药性和免疫监视的调节因子
BBA Clin. 2016 Aug 3;6:87-99. doi: 10.1016/j.bbacli.2016.08.002. eCollection 2016 Dec.
7
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.低剂量白细胞介素-2 治疗可选择性调节系统性红斑狼疮患者的 CD4(+) T 细胞亚群。
Nat Med. 2016 Sep;22(9):991-3. doi: 10.1038/nm.4148. Epub 2016 Aug 8.
8
Phosphatase PP2A is requisite for the function of regulatory T cells.磷酸酶PP2A是调节性T细胞功能所必需的。
Nat Immunol. 2016 May;17(5):556-64. doi: 10.1038/ni.3390. Epub 2016 Mar 14.
9
IL-17 in Chronic Inflammation: From Discovery to Targeting.慢性炎症中的白细胞介素-17:从发现到靶向治疗
Trends Mol Med. 2016 Mar;22(3):230-241. doi: 10.1016/j.molmed.2016.01.001. Epub 2016 Jan 31.
10
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.低剂量白细胞介素-2 选择性纠正系统性红斑狼疮患者调节性 T 细胞缺陷。
Ann Rheum Dis. 2016 Jul;75(7):1407-15. doi: 10.1136/annrheumdis-2015-207776. Epub 2015 Aug 31.